Clinical Trials
11
Active:0
Completed:11
Trial Phases
4 Phases
Phase 1:1
Phase 3:1
Phase 4:3
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (54.5%)Phase 4
3 (27.3%)Phase 1
1 (9.1%)Phase 3
1 (9.1%)Safety of 4Fluart ID Suspension for Injection in Adult Subjects
Phase 1
Completed
- Conditions
- Human Influenza
- First Posted Date
- 2018-02-28
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Target Recruit Count
- 36
- Registration Number
- NCT03448705
- Locations
- 🇭🇺
Drug Research Center, Balatonfüred, Veszprém, Hungary
Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents
Phase 3
Completed
- Conditions
- Human Influenza
- First Posted Date
- 2015-03-13
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Target Recruit Count
- 120
- Registration Number
- NCT02387294
Tolerability and Immunogenicity Study of Fluval AB Suspension for Injection
Phase 4
Completed
- Conditions
- Influenza Prophylaxis
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2021-04-05
- Lead Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Target Recruit Count
- 120
- Registration Number
- NCT01863849
- Locations
- 🇭🇺
Family Doctor's Office, Budapest, Hungary
🇭🇺District Doctor's Office, Szentendre, Hungary
Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season
Phase 4
Completed
- Conditions
- Influenza
- Interventions
- Drug: Fluval AB vaccination
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2012-10-12
- Lead Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Target Recruit Count
- 120
- Registration Number
- NCT01649713
- Locations
- 🇭🇺
District Doctor's Office, Szentendre, Hungary
A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly Subjects
Not Applicable
Completed
- Conditions
- Influenza
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2012-05-21
- Lead Sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Target Recruit Count
- 1206
- Registration Number
- NCT01459276
- Locations
- 🇭🇺
Péter Vajer, Biatorbágy, Pest, Hungary
🇭🇺Barna Bőze, Hatvan, Pest, Hungary
🇭🇺Family Doctor's Office, Pilisvörösvár, Hungary
- Prev
- 1
- 2
- 3
- Next
News
No news found